Why is Novartis India falling/rising?

As of 21-Jul, Novartis India Ltd is currently priced at 1,066.10, reflecting a slight decline of 0.25, or 0.02%. Despite this minor decrease, the stock has shown positive performance over the past month, with a return of 5.05%, significantly outperforming the Sensex, which has declined by 0.25% during the same period. Furthermore, Novartis India is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally upward trend. The company has also experienced a notable increase in investor participation, with delivery volume rising by 116.45% against the 5-day average. Positive financial results, including a substantial growth in operating profit and record earnings per share, contribute to a healthy long-term growth outlook, despite the stock's year-to-date performance being down 9.42% compared to the Sensex's 1.98% increase over the same period.
In the broader market context, Novartis India's recent performance contrasts with the benchmark Sensex, which has shown a slight decline of 0.06% over the past week. While the stock has faced some challenges in the long term, as indicated by its 1-year return of -9.42%, its strong performance over the last three years (+63.19%) and five years (+86.46%) suggests resilience. The low debt-to-equity ratio and robust growth in operating profit further support the stock's potential for recovery, even as it currently experiences a minor decline. Overall, the stock's recent movements reflect a complex interplay of positive financial indicators and broader market dynamics.